Paper Review Records
全部论文审稿周期
28 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
185
天
Subsequent Detection of Clinically Significant Prostate Cancer After Suspicious MRI and an Initial Biopsy Negative for csPCa: A Longitudinal Subgroup Analysis of the MULTIPROS Trial
作者
Wafa D. Aloufi; Magdalena Szewczyk‐Bieda; Ghulam Nabi; Xinyu Zhang; Yilong Zhang; Cheng Wei; Luigi Manfredi展开收起
作者单位
1. Division of Imaging Sciences and Technology, School of Medicine University of Dundee, Ninewells Hospital Dundee UK; 2. Department of Radiological Sciences, College of Applied Medical Sciences Taif University Taif Saudi Arabia; 3. Department of Clinical Radiology Ninewells Hospital and Medical School Dundee UK; 4. Division of Population Health and Genomics, School of Medicine University of Dundee Dundee UK; 5. School of Science and Engineering University of Dundee Dundee UK; 6. Division of Respiratory Medicine and Gastroenterology, School of Medicine University of Dundee, Ninewells Hospital Dundee UK展开收起
58
天
Age Does Not Independently Predict Biochemical Recurrence in Prostate Cancer Following Radical Prostatectomy: A Comparative Analysis of 4223 pT2N0R0 Patients
作者
Mehdi Kardoust Parizi; Pierre I. Karakiewicz; Piotr Chlosta; Peter Nyirády; Tamás Fazekas; Pawel Rajwa; Shahrokh F. Shariat展开收起
作者单位
1. Department of Urology, Austrian Comprehensive Cancer Center Medical University of Vienna Vienna Austria; 2. Department of Urology, Shariati Hospital Tehran University of Medical Sciences Tehran Iran; 3. Uro‐Oncology Research Center Tehran University of Medical Sciences Tehran Iran; 4. Cancer Prognostics and Health Outcomes Unit, Division of Urology University of Montreal Health Center Montreal Quebec Canada; 5. Department of Urology Jagiellonian University Medical College Kraków Poland; 6. Department of Urology Semmelweis University Budapest Hungary; 7. Second Department of Urology Centre of Postgraduate Medical Education Warsaw Poland; 8. Department of Urology Weill Cornell Medicine New York New York USA; 9. Department of Urology University of Texas Southwestern Dallas Texas USA; 10. College of Medical Health Technologies Al‐Turath University Baghdad Iraq; 11. Hourani Center for Applied Scientific Research Al‐Ahliyya Amman University Amman Jordan展开收起
73
天
Real‐World HRR Testing Pathways and Patterns of Detected Alterations in Prostate Cancer From the Multinational ARON‐3 Study
作者
Lorena Incorvaia; Veronica Mollica; Ondřej Fiala; Kazutoshi Fujita; Yüksel Ürün; Bohuslav Melichar; Javier Molina‐Cerrillo; Teresa Alonso‐Gordoa; Umberto Basso; Maria T. Bourlon; Emmanuel Seront; Ugo De Giorgi; Maria José Juan Fita; Pasquale Rescigno; Tarek Taha; Fernando C. Maluf; Alexandr Poprach; Simona De Summa; Tomas Buchler; Luca Galli; Jindrich Kopecky; Gaetano Aurilio; Jakub Kucharz; Carlo Messina; Gabriel Berlingieri Polho; Sarah Scagliarini; Francesco Grillone; Diogo Assed Bastos; Luigi Formisano; Gian Paolo Spinelli; Alessandra Mosca; Alessandro Rizzo; Aristotelis Bamias; Fernando Sabino Marques Monteiro; Andrey Soares; Francesco Massari; Andrew J. Armstrong; Matteo Santoni展开收起
作者单位
1. Department of Precision Medicine in Medical Surgical and Critical Care (Me.Pre.C.C.), Section of Medical Oncology, University of Palermo Palermo Italy; 2. Medical Oncology, IRCCS Azienda Ospedaliero‐Universitaria di Bologna Bologna Italy; 3. Department of Oncology and Radiotherapeutics Faculty of Medicine and University Hospital in Pilsen, Charles University Pilsen Czech Republic; 4. Biomedical Center, Faculty of Medicine in Pilsen Charles University Pilsen Czech Republic; 5. ARON Research Foundation ETS Macerata Italy; 6. Department of Urology, Faculty of Medicine Kindai University Kindai Japan; 7. Medical Oncology, Ankara University Medical Faculty Ankara Turkey; 8. Department of Oncology Faculty of Medicine and Dentistry, Palacký University Olomouc Czech Republic; 9. Medical Oncology Department Hospital Universitario Ramón y Cajal Madrid Spain; 10. Oncology 1 Unit, Department of Oncology Istituto Oncologico Veneto IOV IRCCS Padova Italy; 11. Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán Mexico City Mexico; 12. Institut Roi Albert II, Department of Medical Oncology Cliniques Universitaires Saint Luc Brussel Belgium; 13. Department of Medical Oncology IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori” Meldola Italy; 14. Medical Oncology, Fundación Instituto Valenciano de Oncología Valencia Spain; 15. Translational and Clinical Research Institute, Centre for Cancer Newcastle University Newcastle upon Tyne UK; 16. Royal Marsden NHS Foundation Trust London UK; 17. Hospital Israelita Albert Einstein São Paulo Brazil; 18. Hospital Beneficência Portuguesa São Paulo Brazil; 19. Masaryk Memorial Cancer Institute, Brno, Czech Republic ‐ Faculty of Medicine Masaryk University Brno Czech Republic; 20. Unità di Diagnostica Molecolare e Farmacogenetica, IRCCS Istituto Tumori Giovanni Paolo II Bari Bari Italy; 21. Department of Oncology Second Faculty of Medicine, Charles University and University Hospital Motol and Homolka Prague Czech Republic; 22. Medical Oncology Unit 2, Azienda Ospedaliera Universitaria Pisana Pisa Italy; 23. Department of Clinical Oncology and Radiotherapy University Hospital Hradec Kralove Hradec Kralove Czech Republic; 24. Division of Cancer Prevention and Genetics, IRCCS European Institute of Oncology Milan Italy; 25. Department of Uro‐Oncology Maria Sklodowska‐Curie National Research Institute of Oncology Warsaw Warsaw Poland; 26. Oncology Unit, A.R.N.A.S. Civico Palermo Italy; 27. Hospital Sirio‐Libanês de São Paulo São Paulo Brazil; 28. Department of Medical Oncology AORN “A. Cardarelli” Naples Italy; 29. Medical Oncology Unit Presidio Ospedaliero Pugliese Ciaccio, Azienda Ospedaliera Universitaria “Renato Dulbecco” Catanzaro Italy; 30. Department of Medicine and Surgery Federico II University Naples Italy; 31. Territorial Oncology Operative Complex Unit ‐ Casa Della Salute di Aprilia ‐ ASL Latina Latina Italy; 32. Oncology Department Candiolo Cancer Institute Torino Italy; 33. Bed Management Presa in Carico, TDM, IRCCS Istituto Tumori “Giovanni Paolo II” Bari Italy; 34. Propaedeutic Department of Internal Medicine, ATTIKON University Hospital, School of Medicine National and Kapodistrian University of Athens Athens Greece; 35. Latin American Cooperative Oncology Group ‐ LACOG Porto Alegre Brazil; 36. Hospital Sírio‐Libanês Brasília Brazil; 37. Department of Medical and Surgical Sciences (DIMEC) University of Bologna Bologna Italy; 38. Duke Cancer Institute Duke University Durham North Carolina USA; 39. Medical Oncology Unit, Macerata Hospital Macerata Italy展开收起
79
天
Insulin‐Like Growth Factor Axis and Survival in Metastatic Hormone‐Sensitive Prostate Cancer: Post‐Hoc Analysis From the ENZAMET Phase 3 Trial
作者
Michael A. Cilento; Hui‐Ming Lin; Nicole Yeung; Rachel M.N. Kim; Neil Portman; Martin R. Stockler; Andrew J. Martin; Vinod Subhash; Sonia Yip; Lisa M. Butler; Ian C. Marschner; Peter J. Meikle; Arun A. Azad; Ian D. Davis; Lisa G. Horvath; Christopher J. Sweeney展开收起
作者单位
1. South Australian Immunogenomics Cancer Institute Adelaide University Adelaide Australia; 2. Department of Medical Oncology Royal Adelaide Hospital Adelaide Australia; 3. Australia and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) Sydney Australia; 4. Garvan Institute of Medical Research Sydney Australia; 5. School of Clinical Medicine University of New South Wales Sydney Australia; 6. NHMRC Clinical Trials Centre University of Sydney Camperdown Australia; 7. University of Sydney Camperdown Australia; 8. Department of Medical Oncology Chris O'Brien Lifehouse Sydney Australia; 9. The University of Queensland Brisbane Australia; 10. Baker Heart and Diabetes Institute Melbourne Australia; 11. Department of Cardiovascular Research Translation and Implementation La Trobe University Melbourne Australia; 12. Department of Medical Oncology Peter MacCallum Cancer Centre Melbourne Australia; 13. Sir Peter MacCallum Department of Oncology University of Melbourne Melbourne Australia; 14. Monash University Melbourne Australia; 15. Eastern Health Melbourne Australia展开收起
476
天
Years of Life Lost in Incidental Prostate Cancer
作者
Fabian Falkenbach; Mattia Longoni; Andrea Marmiroli; Quynh Chi Le; Calogero Catanzaro; Michele Nicolazzini; Federico Polverino; Jordan A. Goyal; Riccardo Schiavina; Alessandro Volpe; Gennaro Musi; Felix K. H. Chun; Alberto Briganti; Francesco Montorsi; Fred Saad; Shahrokh F. Shariat; Lars Budäus; Markus Graefen; Pierre I. Karakiewicz展开收起
作者单位
1. Cancer Prognostics and Health Outcomes Unit, Division of Urology University of Montreal Health Center Montreal Quebec Canada; 2. Martini‐Klinik Prostate Cancer Center University Medical Center Hamburg‐Eppendorf Hamburg Germany; 3. Department of Urology University Hospital Heidelberg Heidelberg Germany; 4. Division of Experimental Oncology/Unit of Urology, URI, Urological Research Institute IRCCS San Raffaele Scientific Institute Milan Italy; 5. Vita‐Salute San Raffaele University Milan Italy; 6. Department of Urology IEO European Institute of Oncology, IRCCS Milan Italy; 7. Department of Oncology and Haemato‐Oncology Università degli Studi di Milano Milan Italy; 8. Department of Urology, Goethe University Frankfurt University Hospital Frankfurt am Main Germany; 9. Department of Urology University of Bologna, St. Orsola‐Malpighi Hospital Bologna Italy; 10. Department of Translational Medicine, Division of Urology, University of Eastern Piedmont Maggiore della Carità Hospita Novara Italy; 11. Department of Oncology, Division of Urology University of Turin Orbassano Italy; 12. Department of Neurosciences, Science of Reproduction and Odontostomatology University of Naples Federico II Naples Italy; 13. Department of Urology, Comprehensive Cancer Center Medical University of Vienna Vienna Austria; 14. Department of Urology Weill Cornell Medical College New York New York USA; 15. Department of Urology University of Texas Southwestern Medical Center Dallas Texas USA; 16. Hourani Center for Applied Scientific Research Al‐Ahliyya Amman University Amman Jordan; 17. Department of Urology University Medical Center Hamburg‐Eppendorf Hamburg Germany展开收起
49
天
Temporal Trends of Metastatic Prostate Cancer in the Prostate‐Specific Membrane Antigen Positron Emission Tomography Era in the United States
作者
Leonardo Quarta; Maximilian Filzmayer; Michele Petix; Filippo Orlandi; Jordan A. Goyal; Felix K. H. Chun; Matteo Ferro; Salvatore Micali; Shahrokh F. Shariat; Francesco Barletta; Armando Stabile; Giorgio Gandaglia; Francesco Montorsi; Fred Saad; Alberto Briganti; Pierre I. Karakiewicz展开收起
作者单位
1. Cancer Prognostics and Health Outcomes Unit University of Montréal Health Center, Division of Urology Montréal Québec Canada; 2. Division of Experimental Oncology/Unit of Urology, URI, Urological Research Institute IRCCS San Raffaele Scientific Institute Milan Italy; 3. Vita‐Salute San Raffaele University Milan Italy; 4. Department of Urology, University Hospital Goethe University Frankfurt Frankfurt am Main Germany; 5. Department of Urology ASST Santi Paolo e Carlo Milan Italy; 6. Università degli Studi di Milano Milan Italy; 7. Department of Urology, AOU di Modena University of Modena and Reggio Emilia Modena Italy; 8. Department of Urology, Comprehensive Cancer Center Medical University of Vienna Vienna Austria; 9. Department of Urology Weill Cornell Medical College New York New York USA; 10. Department of Urology University of Texas Southwestern Medical Center Dallas Texas USA; 11. Hourani Center for Applied Scientific Research Al‐Ahliyya Amman University Amman Jordan展开收起
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
